As of June 30, 2026, Aurora Spine Corp carries a market capitalization of 13.67M, placing it among publicly traded companies globally. Its enterprise value stands at 16.79M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 13.67M |
| Enterprise Value | 16.79M |
As of June 30, 2026, Aurora Spine Corp has 78.09M shares outstanding.
| Shares Outstanding | 78.09M |
These figures are as of June 30, 2026. The price-to-sales ratio is 0.79, and the price-to-book ratio stands at 4.84.
| PS Ratio | 0.79 |
| PB Ratio | 4.84 |
| P/TBV Ratio | 6.08 |
| P/FCF Ratio | 64.03 |
| P/OCF Ratio | 20.11 |
As of June 30, 2026, Aurora Spine Corp trades at an EV/EBITDA multiple of 110.73 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.96 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 16.79M versus a market cap of 13.67M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 0.96 |
| EV / EBITDA | 110.73 |
As of June 30, 2026, Aurora Spine Corp maintains a current ratio of 2.25, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 123.31, indicating elevated leverage, while an interest coverage ratio of 0.98 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.25 |
| Quick Ratio | 1.02 |
| Debt / Equity | 123.31 |
| Debt / EBITDA | 22.98 |
| Interest Coverage | 0.98 |
Over the twelve months ended June 30, 2026, Aurora Spine Corp posted a negative return on equity (ROE) of -36.03, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -11.91, reflecting losses generated across the asset base. Inventory turnover of 1.88 indicates how many times Aurora Spine Corp sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -36.03 |
| Return on Assets (ROA) | -11.91 |
| Inventory Turnover | 1.88 |
As of the close on November 16, 2026, Aurora Spine Corp's stock has declined approximately 68.48% over the past 52 weeks. The 50-day moving average sits at 0.11, while the 200-day moving average is 0.17.
| 52-Week Price Change | -68.48% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.17 |
Over the twelve months ended June 30, 2026, Aurora Spine Corp generated 17.55M in revenue and converted that into -1.22M in net income, yielding earnings per share of -0.02. EBITDA reached 151,607.00, while operating income came in at -891,694.00.
| Revenue | 17.55M |
| Gross Profit | 10.81M |
| Operating Income | -891,694.00 |
| Pretax Income | -1.22M |
| Net Income | -1.22M |
| EBITDA | 151,607.00 |
| EBIT | -891,694.00 |
| Earnings Per Share (EPS) | -0.02 |
As of June 30, 2026, Aurora Spine Corp holds 362,634.00 in cash and equivalents against 3.48M in total debt, resulting in a net debt position of 2.55M. Total book value stands at 2.83M, with working capital of 3.67M providing operational flexibility.
| Cash & Cash Equivalents | 362,634.00 |
| Total Debt | 3.48M |
| Net Debt | 2.55M |
| Equity (Book Value) | 2.83M |
| Book Value Per Share | 0.04 |
| Working Capital | 3.67M |
Aurora Spine Corp produced 691,257.00 in operating cash flow over the twelve months ended June 30, 2026. After subtracting -474,177.00 in capital expenditures, free cash flow totaled 217,080.00 - equivalent to 0.00 per share.
| Operating Cash Flow | 691,257.00 |
| Capital Expenditures | -474,177.00 |
| Free Cash Flow | 217,080.00 |
Over the twelve months ended June 30, 2026, Aurora Spine Corp posted a gross margin of 61.61, reflecting its pricing power and cost economics. The operating margin of -5.08 and net profit margin of -6.95 provide insight into operational efficiency.
| Gross Margin | 61.61 |
| Operating Margin | -5.08 |
| Pretax Margin | -6.95 |
| Profit Margin | -6.95 |
| EBITDA Margin | 0.86 |
These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 1.56, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.75, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Aurora Spine Corp shareholders.
| Shareholder Yield | 2.75 |
| FCF Yield | 1.56 |
As of June 30, 2026, Aurora Spine Corp has an Altman Z-Score of -1.17, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.17 |
Already premium?